Recent Company News

• 09:55 AM ET Jul 04, 2025
  

  Swiss pharma stocks move higher; possibly on back of headline saying US-Swiss trade deal likely to contain assurances on Pharma levy

• 02:46 AM ET Jun 26, 2025
  

  Chugai Pharmaceutical applies for additional tumor-agnostic indication of Alecensa with MHLW (¥7583.0000, 0)

• 05:15 PM ET Jun 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:03 AM ET Jun 23, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:22 PM ET Jun 24, 2025
  

  FDA investigating deaths due to acute liver failure in non-ambulatory Duchenne Muscular Dystrophy patients following treatment with Sarepta Therapeutics' ELEVIDYS ($18.98, 0.00)

• 11:49 AM ET Jun 24, 2025
  

  TD Cowen comments on Regeneron matching program, copay support for anti-VEGF treatments

• 07:06 AM ET Jun 23, 2025
  

  Lineage Cell Therapeutics reports 36-month results from OpRegen trial presented at Clinical Trials at the Summit 2025 ($0.95, 0.00)

• 02:55 AM ET Jun 23, 2025
  

  StreetAccount Summary - European pre-market trading update